pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    ART-4215
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Artios Pharma Ltd
  • Phase 2
    ART-6043
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Artios Pharma Ltd
  • Phase 2
    ARTHEx-01
    Myotonic Dystrophy ARTHEx Biotech SL
← prev
page 56 of 231
next →
131
Pain89
Neurology1
ARTICAINE
ARTICAINE (ARTICAINE HYDROCHLORIDE AND EPINEPHRINE)
no indication
DEPROCO
  • Phase 2
    ARTS-021
    Endometrial Cancer Avenzo Therapeutics Inc
  • Phase 2
    ARTS-023
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Avenzo Therapeutics Inc
  • Phase 2
    ARV-806
    Colorectal Cancer$ARVN ARVINAS, INC.
  • Phase 1
    ARX-305
    Renal Cell Carcinoma Ambrx Biopharma Inc
  • Phase 1
    ARX-517
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ambrx Biopharma Inc
  • Preclinical
    AS-00491
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Preclinical
    AS-202
    Amyotrophic Lateral Sclerosis$TAK TAKEDA PHARMACEUTICAL CO LTD
  • Phase 2
    ASC-30
    Obesity Ascletis Pharma Inc
  • Preclinical
    ASC-35
    Obesity Ascletis Pharma Inc
  • Preclinical
    ASC-36
    Obesity Ascletis Pharma Inc
  • Preclinical
    ASC-37
    Obesity Ascletis Pharma Inc
  • Preclinical
    ASC-39
    Obesity Ascletis Pharma Inc
  • Phase 1
    ASC-47
    Obesity Gannex Pharma Co Ltd
  • Phase 1
    ASC-50
    Plaque Psoriasis (Psoriasis Vulgaris) Ascletis Pharma Inc
  • Phase 1
    ASC-60
    Acne Vulgaris$SGMT Sagimet Biosciences Inc.
  • Phase 2
    ASC-618
    Hemophilia A (Factor VIII Deficiency) ASC Therapeutics Inc
  • Phase 1
    ASC-930
    Graft Versus Host Disease (GVHD) ASC Therapeutics Inc
  • Preclinical
    ASD-004
    Breast Cancer Asdera LLC
  • Preclinical
    ASD-005
    Alzheimer's Disease Asdera LLC
  • Preclinical
    ASD-006
    Atherosclerosis Asdera LLC
  • Phase 1
    ASD-141
    Solid Tumor Ascendo Biotechnology Inc
  • ASENAPINE
    ASENAPINE
    no indication SIGMAPHARM LABS LLC
  • pre_registration
    ASN-006
    Venous Thromboembolism Auson Pharmaceuticals Inc
  • Phase 2
    ASP-2957
    X-Linked Myotubular Myopathy (XLMTM or MTM) Astellas Pharma Inc
  • Phase 2
    ASP-7316
    Juvenile Macular Degeneration (Stargardt Disease) Astellas Pharma Inc
  • ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
    ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
    no indication MICRO LABS